Emily Fisher is a breast cancer survivor and medical cannabis patient who is reshaping the future of cannabis healthcare. Her personal journey—finding life-changing relief through cannabis during cancer treatment—revealed both the plant’s powerful therapeutic potential and the urgent need for evidence-based guidance and broader patient access.

Motivated by this insight, Emily founded Leafwell, a pioneering healthtech and data company transforming how people access and understand medical cannabis. Under her leadership, Leafwell has served over 500,000 patients across 38 states and attracts more than 1 million monthly visitors to its education platform.

Emily has built one of the most trusted ecosystems in the industry—connecting licensed providers, dispensaries, and patients through personalized education, real-world outcomes data, and scalable, tech-enabled care. She is also advancing efforts to establish cannabis as a reimbursable, mainstream therapy grounded in science, safety, and compassion.

With a mission rooted in access, education, and research, Emily is shifting public perception, informing policy, and driving meaningful change in healthcare—proving that cannabis is not just a plant, but a vital tool for healing when treated with the rigor of modern medicine.